OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ponatinib‐review of historical development, current status, and future research
Hagop M. Kantarjian, Helen T. Chifotides, Fadi G. Haddad, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1576-1585
Closed Access | Times Cited: 5
Hagop M. Kantarjian, Helen T. Chifotides, Fadi G. Haddad, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1576-1585
Closed Access | Times Cited: 5
Showing 5 citing articles:
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
Elias Jabbour, Hagop M. Kantarjian
American Journal of Hematology (2024) Vol. 99, Iss. 11, pp. 2191-2212
Open Access | Times Cited: 13
Elias Jabbour, Hagop M. Kantarjian
American Journal of Hematology (2024) Vol. 99, Iss. 11, pp. 2191-2212
Open Access | Times Cited: 13
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission
Anna Candoni, Patrizia Chiusolo, Davide Lazzarotto, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2108-2108
Open Access | Times Cited: 4
Anna Candoni, Patrizia Chiusolo, Davide Lazzarotto, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2108-2108
Open Access | Times Cited: 4
Ponatinib: A Review of the History of Medicinal Chemistry behind Its Development
Mayara S.S. do Nascimento, Stefany Moura, L. Gonzalo Parra, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1361-1361
Open Access | Times Cited: 1
Mayara S.S. do Nascimento, Stefany Moura, L. Gonzalo Parra, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1361-1361
Open Access | Times Cited: 1
Application and Progress of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia
慧娟 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 1513-1520
Closed Access
慧娟 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 1513-1520
Closed Access
Successful Treatment-Free Remission After Ponatinib Discontinuation in Pretreated Patients with Chronic Myeloid Leukemia in Chronic Phase
Fadi G. Haddad, Koji Sasaki, Jayastu Senapati, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Fadi G. Haddad, Koji Sasaki, Jayastu Senapati, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
